Jason Luke, MD, FACP, University of Pittsburgh, Pittsburgh, PA, discusses the use of circulating tumor DNA (ctDNA) in clinical practice for melanoma. CtDNA can predict the likelihood of recurrence following surgery, however, ctDNA is not as easily detected in melanoma as other tumor types. This interview took place at the American Association for Cancer Research (AACR) Annual Meeting 2023 in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.